IndiaInfoline » Markets » NATCOPHARM

Natco Pharma Ltd - Share Price

NATCOPHARM

Open

825.00

Prev. Close

820.75

Turnover (lac.)

2,188

Day's High

825.00

Day's Low

799.05

52 Week's High

996.00

52 Week's Low

402.55

Book Value

226

Face Value

2

Mkt Cap (Cr.)

14,627

P/E

42.29

EPS

19.38

Divi. Yield

0.82

Natco Pharma LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Natco Pharma LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd613.4048.85144,991.81555.550.663,366.01106.10
Divis Laboratories Ltd3,519.2549.4691,926.46461.240.461,656.48313.47
Dr Reddys Laboratories Ltd4,408.7531.1574,057.63443.700.563,397.50979.38
Cipla Ltd812.3023.9463,670.05698.930.513,689.88233.61
Aurobindo Pharma Ltd883.8017.1651,164.16740.510.343,701.14246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Natco Pharma LtdSummary & Reports

No Company Summary found

Registered Office

Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033

Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in

Registrar Office

12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA

Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com

Latest Release by natco-pharma-ltd-share-price

View

- <

Reco. Price

Feb 26,2021 01:03 PM

Target Price

Target Returns:

0.00%

Result Express

Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates

Mar 02, 2021 03:25 PM

The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    11 Feb 2021

    Effective. Date

    22 Feb 2021

    Divi. Type

    Interim 3

    Divi.(%)

    50

    Divi. Amt.

    1

    Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More

  • Purpose

    Board Meeting

    Exp. Date

    11 Feb 2021

    Annc. Date

    03 Feb 2021

    NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More

  • Purpose

    Dividend

    Annc. Date

    12 Nov 2020

    Effective. Date

    24 Nov 2020

    Divi. Type

    Interim 2

    Divi.(%)

    150

    Divi. Amt.

    3

    Unaudited Financial Results for the Quarter and Half year ended 30th September, 2020... More